• English
    • Persian
  • English 
    • English
    • Persian
  • Login
View Item 
  •   KR-TBZMED Home
  • TBZMED Published Academics Works
  • Published Articles
  • View Item
  •   KR-TBZMED Home
  • TBZMED Published Academics Works
  • Published Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces

Thumbnail
View/Open
785-Article Text-1053-1-10-20151221.pdf (290.5Kb)
Date
2015
Author
Ramezani, F
Alavian, SM
Sadeghi, A
Khedive, A
Ghalichi, L
Norouzi, M
Karimzadeh, H
Malekzadeh, R
Montazeri, G
Nejatizadeh, A
Ziaee, M
Abedi, F
Ataei, B
Yaran, M
Sayad, B
Somi, MH
Sarizadeh, G
Sanei-Moghaddam, I
Mansour-Ghanaei, F
Rafatpanah, H
Keyvani, H
Kalantari, E
Saberfiroozi, M
Rezaee, R
Daram, M
Mahabadi, M
Goodarzi, Z
Poortahmasebi, V
Geravand, B
Khamseh, A
Mahmoodi, M
Jazayeri, SM
Metadata
Show full item record
Abstract
Background and Objectives: Iranian chronic HBV carrier's population has shown a unique pattern of genotype D distribution all around the country. The aim of this study was to explore more details of evolutionary history of carriers based on structural surface proteins from different provinces. Materials and Methods: Sera obtained from 360 isolates from 12 Different regions of country were used for amplification and sequencing of surface proteins. A detailed mutational analysis was undertaken. Results: The total ratio for Missense/Silent nucleotide substitutions was 0.96. Sistan and Kermanshah showed the lowest rate of evolution between provinces (P = 0.055). On the other hand, Khorasan Razavi and Khoozestan contained the highest ratio (P = 0.055). The rest of regions were laid between these two extremes. Azarbayjan and Guilan showed the highest proportion of immune epitope distribution (91.3% and 96%, respectively). Conversely, Sistan and Tehran harbored the least percentage (66.6% and 68.8%, respectively). Kermanshah province contained only 5.2%, whereas Isfahan had 54.5% of B cell epitope distribution. In terms of T helper epitopes, all provinces showed a somehow homogeneity: 22.58% (Fars) to 46.6% (Khuzestan). On the other hand, distribution of substitutions within the CTL epitopes showed a wide range of variation between 6.6% (Khuzestan) and 63% (Kermanshah). Conclusion: Further to low selection pressure found in Iranian population, the variations between different regions designate random genetic drift within the surface proteins. These finding would have some applications in terms of specific antiviral regimen, design of more efficient vaccine and public health issues. é 2015, Tehran University of Medical Science. All rights reserved.
URI
http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54227
Collections
  • Published Articles

Related items

Showing items related by title, author, creator and subject.

  • trans-Chalcone prevents insulin resistance and hepatic inflammation and also promotes hepatic cholesterol efflux in high-fat diet-fed rats: modulation of miR-34a-, miR-451-, and miR-33a-related pathways. 

    Karimi-Sales, E; Jeddi, S; Ebrahimi-Kalan, A; Alipour, MR (2018)
    Insulin resistance and inflammation are strongly linked to non-alcoholic fatty liver disease (NAFLD) as a feature of the metabolic syndrome. Furthermore, the role of dysregulation of miR-34a, miR-451, and miR-33a in ...
  • The frequency of hepatitis D virus in patients with hepatitis B in Iran: an increasing rate? 

    Somi, MH; Farhang, S; Miri, SM; Pouri, AA; Mjidi, G; Alavian, SM (2009)
    This study sought to determine the seroprevalence of the hepatitis D virus (HDV), the risk factors and its association with the severity of liver disease. Continuous patients at Tabriz and Tehran Hepatitis Clinics were ...
  • Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013 

    Daryani, NE; Alavian, SM; Somi, MH; Torabi-Nami, M (2013)
    The cross-border symposium on hepatitis C, entitled "why treating now?" was held on 15th May 2013 during the 5th International Tehran Hepatitis Congress. The present report summarizing communicated insights during this ...

Knowledge repository of Tabriz University of Medical Sciences using DSpace software copyright © 2018  HTMLMAP
Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

Browse

All of KR-TBZMEDCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Knowledge repository of Tabriz University of Medical Sciences using DSpace software copyright © 2018  HTMLMAP
Contact Us | Send Feedback
Theme by 
Atmire NV